Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma
Year: 2017
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: University Hospital Zurich, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", National and Kapodistrian University of Athens, Hospital Clínic de Barcelona, Ospedale Papa Giovanni XXIII, National Institute of Oncology, University of Tübingen, Essen University Hospital, Charles University, Medizinische Hochschule Hannover, Istituto Oncologico Veneto, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Isala, National Cancer Center Hospital, University Medical Center of the Johannes Gutenberg University Mainz, Novartis (Switzerland), Array BioPharma (United States), Institut Gustave Roussy, Massachusetts General Hospital
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2762490319